TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+4.56%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.67B
AUM Growth
+$2.67B
(+1.6%)
Cap. Flow
-$9.43M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
35.39%
Holding
233
New
11
Increased
50
Reduced
32
Closed
29
Top Buys
| 1 |
AbbVie
ABBV
|
$29.9M |
| 2 |
Illumina
ILMN
|
$20.5M |
| 3 |
Steris
STE
|
$20.4M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$18.9M |
| 5 |
Humana
HUM
|
$15.5M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$42.2M |
| 2 |
Thermo Fisher Scientific
TMO
|
$33.8M |
| 3 |
UnitedHealth
UNH
|
$29.4M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$23.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$20.7M |
Sector Composition
| 1 | Healthcare | 95.21% |
| 2 | Real Estate | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
76
DELISTED
PRA Health Sciences, Inc.
PRAH
| $8.07M | 0.3% |
79,526
-63,982
| -45% | -$6.49M |
|
77
Ultragenyx Pharmaceutical
RARE
$3.04B
| $8.01M | 0.3% |
97,480
| – | – |
|
78
FibroGen
FGEN
$48.4M
| $7.99M | 0.3% |
194,270
| – | – |
|
|
CCXI
79
DELISTED
ChemoCentryx, Inc.
CCXI
| $7.92M | 0.3% |
+144,447
| New | +$7.92M |
|
80
Cencora
COR
$57.2B
| $7.82M | 0.29% |
80,645
| – | – |
|
81
Molina Healthcare
MOH
$9.6B
| $7.81M | 0.29% |
42,669
+15,133
| +55% | +$2.77M |
|
82
DexCom
DXCM
$30.9B
| $7.64M | 0.29% |
18,544
+11,293
| +156% | +$4.66M |
|
|
RETA
83
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.45M | 0.28% |
76,440
+25,533
| +50% | +$2.49M |
|
84
Medical Properties Trust
MPW
$2.66B
| $7.26M | 0.27% |
411,743
| – | – |
|
85
Teva Pharmaceuticals
TEVA
$21.5B
| $7.08M | 0.27% |
785,851
| – | – |
|
86
Sabra Healthcare REIT
SBRA
$4.56B
| $7.04M | 0.26% |
510,660
| – | – |
|
87
Charles River Laboratories
CRL
$7.99B
| $6.96M | 0.26% |
30,754
+12,287
| +67% | +$2.78M |
|
88
Genmab
GMAB
$16.7B
| $6.77M | 0.25% |
184,779
+168,259
| +1,019% | +$6.16M |
|
89
Agios Pharmaceuticals
AGIO
$2.36B
| $6.54M | 0.25% |
186,964
| – | – |
|
90
Apellis Pharmaceuticals
APLS
$3.51B
| $6.52M | 0.24% |
216,017
+42,523
| +25% | +$1.28M |
|
91
Sutro Biopharma
STRO
$85.6M
| $6.45M | 0.24% |
641,268
| – | – |
|
92
United Therapeutics
UTHR
$17.7B
| $6.42M | 0.24% |
63,513
| – | – |
|
93
CRISPR Therapeutics
CRSP
$4.82B
| $6.38M | 0.24% |
76,222
| – | – |
|
|
TRIL
94
DELISTED
Trillium Therapeutics Inc.
TRIL
| $6.37M | 0.24% |
448,049
| – | – |
|
|
LTC
95
LTC Properties
LTC
$1.67B
| $6.36M | 0.24% |
182,293
| – | – |
|
96
Neurocrine Biosciences
NBIX
$13.5B
| $6.08M | 0.23% |
63,203
-142,947
| -69% | -$13.7M |
|
|
ZGNX
97
DELISTED
Zogenix, Inc.
ZGNX
| $5.98M | 0.22% |
333,402
+117,996
| +55% | +$2.12M |
|
|
CERN
98
DELISTED
Cerner Corp
CERN
| $5.89M | 0.22% |
81,500
| – | – |
|
|
SAGE
99
DELISTED
Sage Therapeutics
SAGE
| $5.88M | 0.22% |
96,211
| – | – |
|
100
Teleflex
TFX
$5.57B
| $5.87M | 0.22% |
17,252
| – | – |
|